Scotland’s legal cannabis industry has reached a significant milestone, with a record number of people obtaining medical cannabis through private prescriptions. According to a newspaper report, NHS waiting lists are leaving many people struggling to get conventional treatment, and more Scots are paying for privately prescribed medical cannabis for conditions such as anxiety, depression, and chronic pain.
According to the report, published in March 2025, 3,440 Scots had private prescriptions for medical cannabis, a figure the newspaper described as unprecedented and one that points to growing demand for alternative healthcare routes.
The Growth of Private Cannabis Prescriptions in Scotland
Demand has grown since what the newspaper describes as Scotland’s first medical cannabis clinic opened in 2019. As reported by the Daily Mail, more individuals are turning to private prescriptions due to difficulties accessing conventional treatments through the NHS.
While cannabis remains a controlled substance in the UK, private clinics offer a legal route to a prescription for those who meet the necessary criteria. This shift in demand indicates a broader trend where individuals seek alternative routes to address their needs when faced with long waiting times in the public healthcare system.
Why Are More Scots Opting for Private Cannabis Prescriptions?
Several factors contribute to the increasing number of private cannabis prescriptions in Scotland:
- NHS waiting times: Delays in receiving conventional healthcare push many to seek alternative options.
- Growing awareness: More individuals are becoming informed about legal access to cannabis through private clinics.
- Changing global attitudes: The rise of legal cannabis markets worldwide influences public perception and policy discussions.
Scotland and the Global Cannabis Movement
Scotland is part of a larger global trend where cannabis regulations are evolving. Many countries now permit some form of legal cannabis use, and medical cannabis laws date back to at least 1996, when California passed its Compassionate Use Act. Regulated adult-use markets exist in countries such as Canada and Uruguay, while Germany allows adults to possess and grow limited amounts of cannabis and to obtain it through non-commercial cultivation associations, without commercial sales, and Malta passed its Authority on the Responsible Use of Cannabis Act in 2021.
Within Europe, certain regions, including the Netherlands and Switzerland, have launched pilot programmes to test legal recreational cannabis markets. Meanwhile, many U.S. states have legalised cannabis for medical use, adult use or both.
Personal Perspective
The rise in private cannabis prescriptions in Scotland highlights a crucial issue—NHS waiting times are leaving many individuals without timely access to the care they need. While private options provide an alternative, they come at a cost that not everyone can afford.
Looking ahead, Scotland may need to consider a more inclusive approach to cannabis access. With other nations progressing toward broader legalisation and regulation, it remains to be seen whether the UK will follow suit or continue relying on private prescriptions as the primary means of access.
